| 2007 |
UNC-46 (LAMP5 ortholog in C. elegans) is a sorting factor that localizes the vesicular GABA transporter (UNC-47/VGAT) to synaptic vesicles; in unc-46 mutants, the transporter is diffusely spread along the axon rather than concentrated at synaptic vesicles, reducing miniature current frequency without affecting amplitude. The transporter recruits UNC-46 to synaptic vesicle precursors in the cell body, and UNC-46 sorts the transporter both at the cell body and during endocytosis at the synapse. |
Genetic loss-of-function (unc-46 mutants), electrophysiology (miniature currents), fluorescence localization of transporter in axons |
Nature neuroscience |
High |
17558401
|
| 2007 |
BAD-LAMP (LAMP5) defines a novel early endocytic compartment in cortical projection neurons distinct from classical lysosomal/endosomal compartments. It is endocytosed and recycles to the plasma membrane through a dynamin/AP2-dependent mechanism. A cryptic lysosomal retention motif in the cytoplasmic tail is actively counteracted by sorting signals that keep LAMP5 away from lysosomes. |
GFP-fusion protein subcellular localization, endocytosis assay in primary neurons and transfected HeLa cells, dynamin/AP2 inhibition experiments |
Journal of cell science |
Medium |
17215451
|
| 2011 |
In human plasmacytoid dendritic cells (pDCs), BAD-LAMP (LAMP5) is localized in the endoplasmic reticulum-Golgi intermediate compartment (ERGIC) and is rapidly lost upon activation by CpG oligonucleotides. |
Immunofluorescence colocalization with ERGIC markers, flow cytometry on freshly isolated CD123+ pDCs before and after CpG stimulation |
Blood |
Medium |
21642595
|
| 2016 |
In the mouse brain, LAMP5 is expressed in subpopulations of GABAergic forebrain neurons and is present at synaptic terminals overlapping with VGAT. LAMP5-deficient mice show altered short-term synaptic plasticity in GABAergic transmission, decreased anxiety, and deficits in olfactory discrimination, but VGAT localization is unaffected, indicating LAMP5 is not required for VGAT trafficking in mammals (unlike its C. elegans ortholog UNC-46). |
LAMP5 knockout mouse, electrophysiology (short-term plasticity), immunofluorescence colocalization with VGAT, behavioral assays |
PloS one |
High |
27272053
|
| 2017 |
BAD-LAMP (LAMP5) controls TLR9 trafficking to LAMP1+ late endosomes in human pDCs, promoting NF-κB activation and TNF production upon DNA detection. BAD-LAMP silencing enhances TLR9 retention in an inducible VAMP3+/LAMP2+/LAMP1- endolysosomal compartment, increasing type I interferon (IFN) signaling. Sustained BAD-LAMP expression thus limits type I IFN production by sorting TLR9 to late endosomes away from the IFN-promoting compartment. |
siRNA silencing of LAMP5 in primary human pDCs, TLR9 colocalization by immunofluorescence, cytokine measurement (IFN, TNF), TGF-β treatment and tumor-derived pDC analysis |
Nature communications |
High |
29030552
|
| 2019 |
LAMP5 is a direct transcriptional target of DOT1L (H3K79 histone methyltransferase) in MLL leukemia and functions as an autophagic suppressor that protects MLL fusion proteins from autophagic degradation. Knockdown of LAMP5 promotes selective autophagic degradation of MLL oncoproteins. |
ChIP (DOT1L at LAMP5 locus), LAMP5 knockdown in leukemia cell lines and primary cells, autophagy flux assays (LC3, autophagic degradation), DOT1L inhibitor treatment, in vivo mouse leukemia model |
Clinical cancer research |
High |
30651276
|
| 2019 |
LAMP5 is expressed exclusively in inhibitory (GABAergic/glycinergic) synaptic terminals in the brainstem and spinal cord. LAMP5 knockout mice show increased auditory and tactile startle responses and larger auditory brainstem response wave amplitudes, consistent with a role in sensorimotor inhibitory processing. VIAAT localization is unaffected in LAMP5 KO, confirming no conserved role in VIAAT trafficking. |
Lamp5 knockout mouse, auditory brainstem response (ABR) recording, acoustic and tactile startle reflex assays, immunofluorescence colocalization with VIAAT |
Molecular brain |
Medium |
30867010
|
| 2022 |
LAMP5 modulates innate immune signaling in MLL-rearranged leukemia by transferring signal flux from interferon signaling endosomes to pro-inflammatory signaling endosomes. LAMP5 depletion inhibits NF-κB signaling and increases type I interferon signaling downstream of TLR/IL-1R activation. IRF7 depletion partially rescues the growth inhibition caused by LAMP5 knockdown (epistasis). LAMP5 is also detectable on the cell surface of MLL-r leukemia cells. |
LAMP5 knockdown in MLL-r leukemia cell lines, NF-κB and IFN pathway reporter assays, IRF7 double-knockdown epistasis, in vivo leukemia model, antibody-drug conjugate targeting surface LAMP5 |
Haematologica |
Medium |
33910331
|
| 2023 |
LAMP5 interacts with ANXA7, and this interaction is disrupted by an Asp411 mutation in ANXA7. LAMP5 overexpression stabilizes lysosomal acidic environment and promotes autophagy flux, counteracting the effects of ANXA7 downregulation on autophagy inhibition and apoptosis activation after OGD/R injury in neurons. ANXA7 activation stabilizes LAMP5 protein expression. |
Co-immunoprecipitation (ANXA7-LAMP5 interaction), Asp411 mutation analysis, LAMP5 overexpression in OGD/R neuronal model, lysosomal acidification assay, autophagy flux assay, apoptosis assay |
Cell death discovery |
Medium |
37620352
|
| 2024 |
LAMP5-AS1 lncRNA recruits the H3K79 histone methyltransferase DOT1L to the LAMP5 locus, directly activating LAMP5 transcription. Blocking the LAMP5-AS1–LAMP5 axis enhances autophagic degradation of MLL fusion proteins. |
ChIRP assay (LAMP5-AS1 at LAMP5 locus), ChIP (DOT1L/H3K79me2 at LAMP5 locus), RNA FISH + immunofluorescence colocalization, LC3B puncta and TEM for autophagy flux, in vivo mouse survival |
Experimental hematology & oncology |
Medium |
38374003
|
| 2025 |
LAMP5 interacts with IRF4 and prevents its degradation through the autophagy-lysosome pathway in multiple myeloma cells. LAMP5 enhances the interaction between IRF4 and the nuclear transport protein KPNA2, facilitating IRF4 nuclear transport and preventing its cytoplasmic retention and subsequent autophagy-lysosome degradation. Nuclear IRF4 promotes c-MYC transcription, and c-MYC positively feeds back to activate LAMP5 transcription. Pyrazofurin disrupts the LAMP5–IRF4 interaction, leading to IRF4 degradation. |
Co-immunoprecipitation (LAMP5-IRF4 and IRF4-KPNA2), nuclear/cytoplasmic fractionation, autophagy-lysosome inhibitor experiments, ChIP (IRF4 at c-MYC locus; c-MYC at LAMP5 locus), high-throughput drug screening, in vitro/in vivo myeloma models |
Oncogene |
Medium |
40721659
|